Sources: CBC
Pfizer and its German partner BioNTech begin a clinical trial to test the safety and immune response of their Omicron-specific COVID-19 vaccine for adults under the age of 55 years. 2022-01-25
The European Commission signs a third contract with Pfizer and BioNTech to secure 1.8 billion doses of its vaccine. 2021-05-20
Pfizer and BioNTech begin a clinical trial testing of their COVID-19 vaccine on healthy children between the ages of six months and 11 years, which is considered a crucial step towards vaccinating children. 2021-03-25
Novartis signs an agreement with Pfizer and BioNTech to help produce their vaccine. 2021-01-29
Canadian Prime Minister Justin Trudeau announces that the country will double its order of the Pfizer-BioNTech vaccine from 20 million to 40 million doses. 2021-01-12
Singapore officially begins its vaccination campaign against COVID-19, with healthcare workers being among the first to receive the Pfizer-BioNTech vaccine tozinameran. 2020-12-30
Chile begins its vaccination campaign against COVID-19 after the arrival of 10,000 doses of Pfizer-BioNTech vaccine to the country. 2020-12-24
Kuwait's Ministry of Health approves an Emergency Use Authorization of the Pfizer-BioNtech vaccine. 2020-12-13
Pfizer and BioNTech announce that they have started shipping their vaccine from a Michigan facility to all 50 states. 2020-12-13
Prime Minister Justin Trudeau says that the country will receive 240,000 doses of Pfizer and BioNTech’s vaccine candidate by the end of the year. 2020-12-7